Maurin, Wilfredo G.

HRN: 13-81-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/25/2025
07/31/2025
IV
600 Mg
Q 6 Hrs
Nonhealing Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: